Prescription drug · ANDA
Meloxicam NDC 80425-0585
Meloxicam 15 mg/1 · Tablet · Oral · Advanced Rx of Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80425-0585-1 | 80425058501 | 30 TABLET in 1 BOTTLE (80425-0585-1)Marketed from Jun 18, 2026 | |
| 80425-0585-2 | 80425058502 | 60 TABLET in 1 BOTTLE (80425-0585-2)Marketed from Jun 18, 2026 | |
| 80425-0585-3 | 80425058503 | 90 TABLET in 1 BOTTLE (80425-0585-3)Marketed from Jun 18, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Meloxicam
- Generic name (nonproprietary)
- meloxicam
- Active ingredients
- Meloxicam — 15 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077882
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 80425-0585_57126403-c27a-e7d2-e063-6294a90abea6SPL ID 57126403-c27a-e7d2-e063-6294a90abea6SPL set ID 548ec3b7-2b6d-cd9e-e063-6394a90a78ffRxCUI 152695UNII VG2QF83CGL
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480425058501followed by a unit qualifier and the quantityPackage 80425-0585-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
<p>Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for:</p> <ul> <li>Osteoarthritis (OA) ( <a href="#Section_1.1">1.1</a>)</li> <li>Rheumatoid Arthritis (RA) ( <a href="#Section_1.2">1.2</a>)</li> <li>Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg ( <a href="#Section_1.3">1.3</a>)</li> </ul> Meloxicam tablets are a non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥60 kg ( 1.3 ) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see Clinical Studies (14.1) ] . 1.2 Rheumat…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077882
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-3056 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Terrain Pharmaceuticals, Inc. | 53225-3015 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Terrain Pharmaceuticals, Inc. | 53225-3075 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Direct_Rx | 72189-684 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Direct_Rx | 72189-683 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0558 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0563 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0559 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0584 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0586 |